Skin Lightening Accelerator Pack

Manufacturer
Rodan & Fields, LLC. | Cosmetic Enterprises Ltd
Effective date
2015-08-14
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:30:52

Label at a glance#

ProductSkin Lightening Accelerator Pack
Active ingredientHYDROQUINONE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Hyrodquinone 2%                   Skin Lightener

OTC - PURPOSE SECTION

Uses

For the gradual fading of dark areas such as freckles, age and liver spots, or pigmnet in the skin that may occur in pregnancy or from the use of oral contraceptives

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Contol Center immediately

INDICATIONS & USAGE SECTION

Some users of thsi product may experience a mild skin irritation. If skin irritation becomes severs, stope use and consult a doctor

WARNINGS SECTION

Warnings

For external use only

When using this product

  • Avoid contact with eyes
  • do no use on children under 12 years of age unless directed by a doctor

DOSAGE & ADMINISTRATION SECTION

Directions -Skin Lightening Treatment

  • Apply a genourous dime-sized amount evenly over the entire face, avoiding the eye area. Allow product to be absorbed. Do not rinse off. Use once every other day and increase to twice daily as tolerated.
  • Adults: apply a small amount as a thin layer on affected areaonce or twice daily, or use as directed by a doctor. If no improvement is seen after thrre months of treatment, use of this product should be discontinued. Lightening effect of this product may not be noticeable when used on very dark skin.
  • Sun exposure should be limited by using a sunscreen agent, a sun blocking agent, or protective clothing to cover bleached skin when using and after using the product in order to prevent darkening from reocurring
  • Children under 12 years of age: do not use unless directed by a doctor

Directions -Skin Lightening Toner

  • Apply evenly to the entire face with a fresh gauze pad, avoiding the eye area. Do not rinse off. Allow to dry. Use once every other day and increase to twice daily as tolerated.
  • Adults: apply a small amount as a thin layer on affected areaonce or twice daily, or use as directed by a doctor. If no improvement is seen after thrre months of treatment, use of this product should be discontinued. Lightening effect of this product may not be noticeable when used on very dark skin.

  • Sun exposure should be limited by using a sunscreen agent, a sun blocking agent, or protective clothing to cover bleached skin when using and after using the product in order to prevent darkening from reocurringChildren under 12 years of age: do not use unless directed by a doctor

INACTIVE INGREDIENT SECTION

Skin Lightening Treatement

Water, Cetearyl Alcohol, Ethoxydiglycol, PPG-12/SMDI Copolymer, Diethylhexyl Sebacate, Polyacrylamide, Sodium C14-16 Olefin Sulfonate, Arctostaphylos Uva Ursi Leaf Extract, Glycerin, Ceteareth-20, C13-14 Isoparaffin, Dimethicone, Magnesium Ascorbyl Phosphate, Ascorbyl Palmitate, Retinol, Glycine Soja (Soybean) Oil, Glyceryl Stearate, Lactic Acid, PEG-100 Stearate, Tocopheryl Acetate, Citric Acid, Laureth-7, Sodium Metabisulfite, Imidazolidinyl Urea, Methylparaben, Propylparaben, Fragrance, Disodium EDTA, Yellow 5 (CI 19140), Yellow 6 (CI 15985)

Skin Lightening Toner

Water, Ethoxydiglycol, Hamamelis Virginiana (Witch Hazel) Water, Methylpropanediol, Polysorbate 20, Foeniculum Vulgare (Fennel) Fruit Extract, Magnesium Ascorbyl Phosphate, Arctostaphylos Uva Ursi Leaf Extract, PEG-12 Dimethicone, Arnica Montana Flower Extract, Zinc Phenolsulfonate, Kojic Acid, Citrus Medica Limonum (Lemon) Peel Extract, Salicylic Acid, Citric Acid, Sodium Sulfite, Sodijm Metabisulfite, DMDM Hydantoin, Fragrance, Sodium Hydroxide, Yellow 5 (CI 19140), Yellow 6 (CI 15985)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Rodan+Fields

Reverse

Skin Lightening Accelerator Pack

For Stubborn Dark Marks and Pigmentation

Skin Lightening Toner              Skin Lightening Treatment

125 mL/4.2 Fl. Oz                     50 mL/1.7 Fl. Oz

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BoxBox

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
14222-5000-12021-03-23C16284748780-19d75b9cf-f5d8-f424-e053-dadaa90a57ceSkin Lightening Accelerator Pack
14222-5000-12020-01-31C16284748780-19d75b9cf-f5d8-f424-e053-dadaa90a57ceSkin Lightening Accelerator Pack

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
HYDROQUINONEACTIVE INGREDIENTXV74C1N1AE1
HYDROQUINONEACTIVE MOIETYXV74C1N1AE1
.ALPHA.-TOCOPHEROL ACETATEINACTIVE INGREDIENT9E8X80D2L01
ARCTOSTAPHYLOS UVA-URSI LEAFINACTIVE INGREDIENT3M5V3D1X361
ARNICA MONTANA FLOWERINACTIVE INGREDIENTOZ0E5Y15PZ1
ASCORBYL PALMITATEINACTIVE INGREDIENTQN83US2B0N1
C13-14 ISOPARAFFININACTIVE INGREDIENTE4F12ROE701
CETOSTEARYL ALCOHOLINACTIVE INGREDIENT2DMT128M1S1
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QP1
DIETHYLENE GLYCOL MONOETHYL ETHERINACTIVE INGREDIENTA1A1I8X02B1
DIETHYLHEXYL SEBACATEINACTIVE INGREDIENTU9LS47Q72Q1
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1O1
DMDM HYDANTOININACTIVE INGREDIENTBYR0546TOW1
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86K1
FD&C YELLOW NO. 5INACTIVE INGREDIENTI753WB2F1M1
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A81
FENNEL SEEDINACTIVE INGREDIENTG3QC02NIE61
GLYCERININACTIVE INGREDIENTPDC6A3C0OX1
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE41
HAMAMELIS VIRGINIANA TOP WATERINACTIVE INGREDIENTNT00Y05A2V1
IMIDUREAINACTIVE INGREDIENTM629807ATL1
KOJIC ACIDINACTIVE INGREDIENT6K23F1TT521
LACTIC ACIDINACTIVE INGREDIENT33X04XA5AT1
LAURETH-7INACTIVE INGREDIENTZ95S6G82011
LEMON PEELINACTIVE INGREDIENT72O054U6281
MAGNESIUM ASCORBYL PHOSPHATEINACTIVE INGREDIENT0R822556M51
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T1
METHYLPROPANEDIOLINACTIVE INGREDIENTN8F53B3R4R1
PEG-100 STEARATEINACTIVE INGREDIENTYD01N1999R1
PEG-12 DIMETHICONE (300 CST)INACTIVE INGREDIENTZEL54N6W951
POLYACRYLAMIDE (1500 MW)INACTIVE INGREDIENT5D6TC4BRWV1
POLYOXYL 20 CETOSTEARYL ETHERINACTIVE INGREDIENTYRC528SWUY1
POLYSORBATE 20INACTIVE INGREDIENT7T1F30V5YH1
PPG-12/SMDI COPOLYMERINACTIVE INGREDIENT1BK9DDD24E1
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OH1
RETINOLINACTIVE INGREDIENTG2SH0XKK911
SALICYLIC ACIDINACTIVE INGREDIENTO414PZ4LPZ1
SODIUM C14-16 OLEFIN SULFONATEINACTIVE INGREDIENTO9W3D3YF5U1
SODIUM HYDRIDEINACTIVE INGREDIENT23J3BHR95O1
SODIUM METABISULFITEINACTIVE INGREDIENT4VON5FNS3C1
SODIUM SULFITEINACTIVE INGREDIENTVTK01UQK3G1
SOYBEAN OILINACTIVE INGREDIENT241ATL177A1
WaterINACTIVE INGREDIENT059QF0KO0R1
ZINC PHENOLSULFONATEINACTIVE INGREDIENT4O71YT5YB51

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 46 matching rows.

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 2 · 52 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 11 · 618 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION, SUSPENSION / INTRAMUSCULAR1 mgExact identifier — unii candidate
79 equally ranked IID candidates
SODIUM SULFITESODIUM SULFITEVTK01UQK3GSOLUTION / AURICULAR (OTIC)0.02 %w/vExact identifier — unii candidate
18 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION / INTRAVENOUS10 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION, SUSPENSION / INTRAMUSCULAR0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCREAM / VAGINAL22 mgExact identifier — unii candidate
79 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSWAB / TOPICAL0.05 %w/wExact identifier — unii candidate
88 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INTRALESIONAL0.15 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL2 mgExact identifier — unii candidate
88 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KDROPS / NASAL0.1 mg/1mlExact identifier — unii candidate
77 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TDROPS / ORAL1 mg/1mlExact identifier — unii candidate
79 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CSOLUTION / OPHTHALMIC0.2 %w/wExact identifier — unii candidate
43 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TPASTE, DENTIFRICE / DENTAL0.05 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / ORAL100 mgExact identifier — unii candidate
68 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION / NASAL2.8 mg/1mlExact identifier — unii candidate
88 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSUSPENSION / RECTAL271 mgExact identifier — unii candidate
68 equally ranked IID candidates
SODIUM SULFITESODIUM SULFITEVTK01UQK3GSUSPENSION / ORAL1.15 mg/1mlExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHJELLY / NASAL140 mgExact identifier — unii candidate
68 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION / INTRAVASCULAR0.48 mgExact identifier — unii candidate
77 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS225 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CINJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR0.15 %w/vExact identifier — unii candidate
43 equally ranked IID candidates
DIETHYLENE GLYCOL MONOETHYL ETHERDIETHYLENE GLYCOL MONOETHYL ETHERA1A1I8X02BCREAM / TOPICAL1290 mgExact identifier — unii candidate
6 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET, FILM COATED / ORAL1.55 mgExact identifier — unii candidate
75 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TTABLET, EXTENDED RELEASE / ORAL0.17 mgExact identifier — unii candidate
79 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHTABLET, EXTENDED RELEASE / ORAL4.2 mgExact identifier — unii candidate
28 equally ranked IID candidates
DIETHYLENE GLYCOL MONOETHYL ETHERDIETHYLENE GLYCOL MONOETHYL ETHERA1A1I8X02BLOTION / TOPICAL714 mgExact identifier — unii candidate
6 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXAEROSOL / TOPICAL3 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION, SUSPENSION / SOFT TISSUE1 mgExact identifier — unii candidate
77 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHSOLUTION / TOPICAL15 %w/wExact identifier — unii candidate
28 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KTABLET / ORAL100 mgExact identifier — unii candidate
77 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHDROPS / AURICULAR (OTIC)NAExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXPASTE, DENTIFRICE / DENTAL18 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXMOUTHWASH / BUCCAL100 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii candidate
75 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TJELLY / NASAL250 mgExact identifier — unii candidate
79 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSHAMPOO / TOPICAL1 %w/wExact identifier — unii candidate
77 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCREAM, AUGMENTED / TOPICAL2 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION, CONCENTRATE / ORAL0.2 mg/1mlExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSUSPENSION / AURICULAR (OTIC)NAExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION, SOLUTION / INTRAVENOUS45 mgExact identifier — unii candidate
79 equally ranked IID candidates
LACTIC ACIDLACTIC ACID33X04XA5ATCAPSULE / ORAL132 mgExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSYRUP / ORAL40 mgExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXEMULSION / OPHTHALMIC3 mgExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHLIQUID / TOPICAL0.1 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION/ DROPS / OPHTHALMIC0.13 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHSOAP / TOPICAL0.02 %w/wExact identifier — unii candidate
28 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION / AURICULAR (OTIC)0.1 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TGEL / TOPICAL24 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INTRA-ARTICULAR0.24 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHFILM, SOLUBLE / BUCCAL1 mgExact identifier — unii candidate
68 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KTABLET, DELAYED RELEASE / ORAL100 mgExact identifier — unii candidate
77 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / IONTOPHORESIS0.1 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KDROPS / OPHTHALMIC0.05 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KDROPS / AURICULAR (OTIC)0.05 %w/wExact identifier — unii candidate
77 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / IRRIGATION2 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPCONCENTRATE / ORAL5.3 mg/1mlExact identifier — unii candidate
88 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CLOTION / TOPICAL0.2 %w/vExact identifier — unii candidate
43 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KTABLET, EFFERVESCENT / ORAL32 mgExact identifier — unii candidate
77 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL23 mgExact identifier — unii candidate
21 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHTABLET, EXTENDED RELEASE / ORAL0.12 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHCREAM / TOPICAL6 mgExact identifier — unii candidate
68 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
9b2a0259-a5e5-4059-b913-577f0f645549b1a91f30-c2c8-4cd8-955d-f8f1997f8acf2015-08-14WarningsExact identifier
spl set id: b1a91f30-c2c8-4cd8-955d-f8f1997f8acf

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.